21:41 , Jul 18, 2018 |  BC Extra  |  Clinical News

Pfizer's tanezumab meets in Phase III for OA pain

Pfizer Inc. (NYSE:PFE) and partner Eli Lilly and Co. (NYSE:LLY) said tanezumab met the three co-primary endpoints compared with placebo in the Phase III A4091056 trial to treat osteoarthritis pain. Pfizer said the data support...
19:59 , Jul 18, 2018 |  BC Extra  |  Company News

Novartis halts price increases, reports 2Q earnings

Novartis AG (NYSE:NVS; SIX:NOVN) announced Wednesday that it will suspend for the rest of the year price increases in the U.S. The pharma made the announcement in conjunction with the release of its 2Q18 earnings. On...
23:21 , Jul 13, 2018 |  BioCentury  |  Finance

Pause for politics

The near record-setting pace of 1H18 capital markets activity isn’t likely to be replicated this half, but that won’t be because of changes to sector fundamentals. Instead, it’s likely the consequence of macroeconomic and geopolitical...
18:57 , Jul 13, 2018 |  BC Week In Review  |  Company News

Novartis to spin out Alcon unit

Novartis AG (NYSE:NVS; SIX:NOVN) said it intends to spin out its Alcon eye care business, while retaining the pharma’s ophthalmology pharmaceuticals portfolio. The spinout will include Alcon’s surgical and vision care assets, which yielded $6.7 billion...
18:55 , Jul 13, 2018 |  BC Week In Review  |  Company News

For Pfizer's units, three is the magic number

Pfizer Inc. (NYSE:PFE) will reorganize into three distinct business units: Innovative Health, Established Medicines and Consumer Healthcare. The pharma's current structure includes two distinct business units: Pfizer Innovative Health and Pfizer Essential Health. Under the new...
18:49 , Jul 13, 2018 |  BioCentury  |  Finance

Curating Abingworth

With a narrower set of investment strategies and a diversified LP base for its latest fund, Abingworth is seeking double digit returns from the $315 million Bioventures VII. Abingworth’s Kurt von Emster told BioCentury the...
21:35 , Jul 11, 2018 |  BC Extra  |  Company News

For Pfizer's units, three is the magic number

Pfizer Inc. (NYSE:PFE) will reorganize into three distinct business units: Innovative Health, Established Medicines and Consumer Healthcare. The pharma's current structure includes two distinct business units: Pfizer Innovative Health and Pfizer Essential Health. Under the new...
20:06 , Jul 11, 2018 |  BC Extra  |  Politics & Policy

Pfizer creates deadline for Trump drug plan

Pfizer Inc. (NYSE:PFE) Chairman and CEO Ian Read has turned President Donald Trump’s fury over drug price increases into an opportunity to create a de facto deadline for the Trump administration to implement its drug...
22:53 , Jul 9, 2018 |  BC Extra  |  Company News

Trump blasts Pfizer for price hikes, threatens to respond

President Donald Trump threatened to take action against companies for increasing drug prices in a tweet Monday that specifically named Pfizer Inc. (NYSE:PFE). Trump tweeted, “Pfizer & others should be ashamed that they have raised drug...
20:29 , Jul 6, 2018 |  BC Extra  |  Company News

Management tracks: Goldman Sachs, Acceleron

One of China's top healthcare analysts, Richard Yeh, said he is departing Goldman Sachs, where he was in global investment research for Asia Pacific. Several Asia-focused bankers and analysts, including Citigroup's Billy Cho, Bank of...